• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种胆管癌的小鼠模型揭示了 Tensin-4 在肿瘤进展中的作用。

A Mouse Model of Cholangiocarcinoma Uncovers a Role for Tensin-4 in Tumor Progression.

机构信息

de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

Department of Pathology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.

出版信息

Hepatology. 2021 Sep;74(3):1445-1460. doi: 10.1002/hep.31834.

DOI:10.1002/hep.31834
PMID:33768568
Abstract

BACKGROUND AND AIMS

Earlier diagnosis and treatment of intrahepatic cholangiocarcinoma (iCCA) are necessary to improve therapy, yet limited information is available about initiation and evolution of iCCA precursor lesions. Therefore, there is a need to identify mechanisms driving formation of precancerous lesions and their progression toward invasive tumors using experimental models that faithfully recapitulate human tumorigenesis.

APPROACH AND RESULTS

To this end, we generated a mouse model which combines cholangiocyte-specific expression of Kras with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet-induced inflammation to mimic iCCA development in patients with cholangitis. Histological and transcriptomic analyses of the mouse precursor lesions and iCCA were performed and compared with human analyses. The function of genes overexpressed during tumorigenesis was investigated in human cell lines. We found that mice expressing Kras in cholangiocytes and fed a DDC diet developed cholangitis, ductular proliferations, intraductal papillary neoplasms of bile ducts (IPNBs), and, eventually, iCCAs. The histology of mouse and human IPNBs was similar, and mouse iCCAs displayed histological characteristics of human mucin-producing, large-duct-type iCCA. Signaling pathways activated in human iCCA were also activated in mice. The identification of transition zones between IPNB and iCCA on tissue sections, combined with RNA-sequencing analyses of the lesions supported that iCCAs derive from IPNBs. We further provide evidence that tensin-4 (TNS4), which is stimulated by KRAS and SRY-related HMG box transcription factor 17, promotes tumor progression.

CONCLUSIONS

We developed a mouse model that faithfully recapitulates human iCCA tumorigenesis and identified a gene cascade which involves TNS4 and promotes tumor progression.

摘要

背景和目的

早期诊断和治疗肝内胆管癌(iCCA)对于改善治疗效果至关重要,但目前对于 iCCA 前体病变的发生和发展的信息有限。因此,需要使用能够真实再现人类肿瘤发生过程的实验模型,来鉴定驱动癌前病变形成及其向侵袭性肿瘤进展的机制。

方法和结果

为此,我们构建了一种小鼠模型,该模型结合了胆管细胞特异性表达 Kras 与 3,5-二乙氧基羰基-1,4-二氢吡啶(DDC)饮食诱导的炎症,以模拟胆管炎患者的 iCCA 发生。对小鼠前体病变和 iCCA 进行了组织学和转录组学分析,并与人类分析进行了比较。在人类细胞系中研究了肿瘤发生过程中过表达基因的功能。我们发现,在胆管细胞中表达 Kras 并给予 DDC 饮食的小鼠发生胆管炎、胆管增生、胆管内乳头状肿瘤(IPNBs),最终发展为 iCCA。小鼠和人类 IPNBs 的组织学相似,并且小鼠 iCCA 显示出人类黏蛋白产生的大胆管型 iCCA 的组织学特征。在人类 iCCA 中激活的信号通路也在小鼠中被激活。组织切片中 IPNB 和 iCCA 之间过渡区的鉴定,以及对病变的 RNA 测序分析,支持 iCCA 来源于 IPNBs。我们进一步提供了证据表明,Tensin-4(TNS4)在 KRAS 和 SRY 相关 HMG 盒转录因子 17 的刺激下,促进肿瘤进展。

结论

我们开发了一种能够真实再现人类 iCCA 肿瘤发生的小鼠模型,并确定了一个涉及 TNS4 并促进肿瘤进展的基因级联。

相似文献

1
A Mouse Model of Cholangiocarcinoma Uncovers a Role for Tensin-4 in Tumor Progression.一种胆管癌的小鼠模型揭示了 Tensin-4 在肿瘤进展中的作用。
Hepatology. 2021 Sep;74(3):1445-1460. doi: 10.1002/hep.31834.
2
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.胆管癌中的新分子机制:触发肿瘤细胞产生白细胞介素 6 的信号以及 KRAS 挪用的表观遗传介质驱动代谢重编程。
J Exp Clin Cancer Res. 2022 May 26;41(1):183. doi: 10.1186/s13046-022-02386-2.
3
Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct.靶向下一代测序鉴定胆管内乳头状肿瘤的不同临床病理和分子实体。
Mod Pathol. 2019 Nov;32(11):1637-1645. doi: 10.1038/s41379-019-0306-9. Epub 2019 Jun 23.
4
MYC determines lineage commitment in KRAS-driven primary liver cancer development.MYC 决定 KRAS 驱动的原发性肝癌发展中的谱系决定。
J Hepatol. 2023 Jul;79(1):141-149. doi: 10.1016/j.jhep.2023.02.039. Epub 2023 Mar 9.
5
and Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma.并且突变导致胆管细胞和肝细胞衍生的胆管癌。
Cancer Res. 2018 Aug 15;78(16):4445-4451. doi: 10.1158/0008-5472.CAN-17-1123. Epub 2018 Jun 5.
6
MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways.MUC13通过表皮生长因子受体/磷脂酰肌醇-3激酶/蛋白激酶B通路促进肝内胆管癌进展。
J Hepatol. 2020 Apr;72(4):761-773. doi: 10.1016/j.jhep.2019.11.021. Epub 2019 Dec 16.
7
PARP-1 selectively impairs -driven phenotypic and molecular features in intrahepatic cholangiocarcinoma.聚腺苷二磷酸核糖聚合酶-1 选择性损害肝内胆管癌中的 - 驱动表型和分子特征。
Gut. 2024 Sep 9;73(10):1712-1724. doi: 10.1136/gutjnl-2023-331237.
8
Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.胆管内乳头状肿瘤中 APC 和 CTNNB1 的反复突变和激活的 Wnt/β-连环蛋白信号传导:全外显子组测序研究。
Am J Surg Pathol. 2018 Dec;42(12):1674-1685. doi: 10.1097/PAS.0000000000001155.
9
Brahma-Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion.与婆罗门相关的基因1抑制通过减弱祖细胞扩增预防肝纤维化和胆管癌。
Hepatology. 2021 Aug;74(2):797-815. doi: 10.1002/hep.31780. Epub 2021 May 22.
10
Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.胆管腺瘤可能是小胆管型肝内胆管癌的前驱病变。
Histopathology. 2021 Jan;78(2):310-320. doi: 10.1111/his.14222. Epub 2020 Sep 15.

引用本文的文献

1
GFAT1 promotes the progression of hepatocellular carcinoma via enhancing the O-GlcNAcylation of VEZF1.GFAT1通过增强VEZF1的O-连接N-乙酰葡糖胺化促进肝细胞癌进展。
Cell Death Dis. 2025 Aug 26;16(1):647. doi: 10.1038/s41419-025-07975-5.
2
TNS4 promotes lymph node metastasis of gastric cancer by interacting with integrin Β1 and inducing the activation of fibroblastic reticular cell.TNS4通过与整合素β1相互作用并诱导成纤维网状细胞活化来促进胃癌的淋巴结转移。
Cancer Cell Int. 2025 Jun 6;25(1):204. doi: 10.1186/s12935-025-03830-x.
3
PPM1G Inhibits Epithelial-Mesenchymal Transition in Cholangiocarcinoma by Catalyzing TET1 Dephosphorylation for Destabilization to Impair Its Targeted Demethylation of the CLDN3 Promoter.
PPM1G通过催化TET1去磷酸化使其不稳定,从而损害其对CLDN3启动子的靶向去甲基化,抑制胆管癌中的上皮-间质转化。
Adv Sci (Weinh). 2024 Dec;11(47):e2407323. doi: 10.1002/advs.202407323. Epub 2024 Oct 30.
4
Predicting tumor repopulation through the gene panel derived from radiation resistant colorectal cancer cells.通过源自辐射抗性结直肠癌细胞的基因谱预测肿瘤再增殖。
J Transl Med. 2023 Jun 16;21(1):390. doi: 10.1186/s12967-023-04260-x.
5
GepLiver: an integrative liver expression atlas spanning developmental stages and liver disease phases.GepLiver:一个整合的肝脏表达图谱,涵盖了发育阶段和肝脏疾病阶段。
Sci Data. 2023 Jun 10;10(1):376. doi: 10.1038/s41597-023-02257-1.
6
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research.为胆管癌研究选择合适的实验动物模型。
J Clin Transl Hepatol. 2022 Aug 28;10(4):700-710. doi: 10.14218/JCTH.2021.00374. Epub 2022 Feb 11.
7
Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application.肝细胞癌的小鼠模型:分类、进展与应用
Front Oncol. 2022 Jun 30;12:902820. doi: 10.3389/fonc.2022.902820. eCollection 2022.
8
Current Advances in Basic and Translational Research of Cholangiocarcinoma.胆管癌基础与转化研究的当前进展
Cancers (Basel). 2021 Jul 1;13(13):3307. doi: 10.3390/cancers13133307.
9
Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice.基于植入的小鼠胆管癌发生遗传建模的最新进展
Cancers (Basel). 2021 May 11;13(10):2292. doi: 10.3390/cancers13102292.